Category: Allergy

Greer, a leading developer and provider of allergy immunotherapy products and services, has completed enrollment for its pivotal Phase III clinical trial designed to study the efficacy of sublingual-oral immunotherapy (SLIT) as a treatment for adults with allergic rhinoconjunctivitis caused by short ragweed pollen. It is estimated that 30 million Americans are allergic to short […]

Recent scientific findings explain why patients with a rare immunodeficiency disorder are unusually susceptible to certain common infections. By revealing the exact molecular mechanisms involved, they also give us clues as to why some ‘healthy’ people are more prone to these infections than others, and suggest potential treatments.

Share and Enjoy:
These icons link to social bookmarking […]

Scientists in Sydney have identified a process, a synergistic encounter between two molecules, that may account for the extreme allergic reactions some people experience. By silencing at least one of these molecules, it may be possible to treat allergies. The molecules, IL-4 and IL-21, are cytokines or ‘chemical messengers’ produced by […]

Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on the development of novel anti-inflammatory drugs, today announced that it has initiated a Phase II equivalent study of MRX-4, in a nasal aerosol formulation, in 105 patients suffering from allergic rhinitis (AR). The two-arm, randomized, multi-dose, double-blind, placebo-controlled study […]

New research findings suggest that some food-allergic children may not be equipped with enough potentially life-saving medication to reverse a severe allergic reaction. According to research to be published in an upcoming issue of the Journal of Allergy and Clinical Immunology, a second dose of epinephrine - the drug of choice for treating severe allergic […]

invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that its DiaryPRO® field-based ePRO system was used to capture primary efficacy endpoint data in the recently unblinded Phase III study of Pollinex® Quattro, a vaccine being developed by Allergy Therapeutics® plc (AIM:AGY) to treat […]

Moving house or the separation of parents can significantly increase the risk of children developing allergies later on. These are the results from a long-term study correlating life-style, immune system development and allergies, led by the Helmholtz Center for Environmental Research in Leipzig (UFZ), the Helmholtz Zentrum Munchen and the “Institut für Umweltmedizinische Forschung” (IUF) […]

As homeowners across the Midwest begin to recover from recent flooding, a new threat may be looming.Wet walls, damp carpet and other porous materials can serve as breeding grounds for mold, putting many at increased risk for asthma attacks, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).Exposure to mold spores can trigger […]

Hospitals are finding that increasing numbers of adults who are admitted to the hospital for other conditions also have asthma, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Asthma is a chronic disease that causes wheezing, coughing, chest tightness, and difficulty breathing. Causes of the disease are unclear, […]

The World Allergy Organization (WAO) will publish its first Report on the extent of allergy and chronic respiratory diseases worldwide on the 18 June 2008 and has called for immediate collaboration to tackle the current escalation in allergy cases. In the last 20-30 years, the prevalence of […]